CalciMedica Inc
CalciMedica Inc (CALC) Covered Calls
No qualifying covered call setups were found for CALC in the prior session.
Read more
Running CALC covered calls helps you generate consistent income from CalciMedica Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on CalciMedica Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best CALC covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if CALC stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling CALC covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given CalciMedica Inc covered call is worth writing.
CalciMedica, Inc., a clinical-stage biotechnology company, focuses on developing therapies for life-threatening inflammatory diseases with unmet needs. Its proprietary technology targets the inhibition of calcium release-activated (CRAC) channels designs to modulate the immune response and protect against tissue cell injury in life-threatening inflammatory diseases. Its lead product candidate is Auxora, a proprietary intravenous-formulated CRAC channel inhibitor for the treatment of acute pancreatitis, asparaginase-associated acute pancreatitis, and acute kidney injury. The company is based in La Jolla, California.
Income-focused investors, long-term CALC holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling CALC covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best CalciMedica Inc covered calls come to you, already filtered for the metrics that matter.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile—
- Market cap (M$)23
- 52 weeks high-89.72%
- 52 weeks low60.87%
- Analyst recommendationBuy
2.00 - Target price$6.00
204.57% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-08-11
- P/E—
- Future P/E—
- EPS (ttm)-1.31
- EPS growth next 5 years20.76%
As of September 18, 2026
No illustrative rows to display.
As of September 18, 2026
Sell covered calls with the data behind you
Find the best CALC covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.
Start your 14-day free trial→